Chris Hale, CEO of Kountable, said: "Technology and price transparency go hand in hand. Technology platforms have reshaped markets from e-commerce to stock trading, and every time a platform brings transparency, consumers win. Kountable exists to bring accountability, governance and transparency to the most important value chains, so everyone working to improve health outcomes—from manufacturers to distributors and health care providers—can come together to ensure that the efforts they make to deliver health equity improve people's lives. By partnering with FIND, we have the opportunity to support local businesses and their procurement processes in a sustainable way by delivering the best products at competitive prices to healthcare consumers."

Kartik Sharma, Head of Market Shaping at FIND, said: "Pricing remains one of the biggest barriers to diagnostic access. The impact of investment in R&D innovation and global price negotiations are eroded due to a lack of supply chain governance, risks and inefficiencies that result in often-prohibitive prices to end users and patients. This initiative has been designed to generate evidence for solving these issues and enable fair and predictable pricing."


The impact assessment of the trade finance and governance initiative will run for 12 months, until July 2022.


SOURCE Kountable; FIND

Back to HCB News

Business Affairs Homepage